As per the research report, the size of the Asia Pacific Wound Debridement Products market size is valued at USD 115.4 million in 2019. It is expected to grow at a CAGR of 7.5% to reach USD 165.67 million by 2024 during the forecast period 2019-2024. It captures 20% of the global market.
Wound debridement is a process of removal of contaminated, dead tissue along with foreign substances from a wound. Wound debridement products help to decrease various types of toxins, microbes, and other foreign material that hinders the healing of the wound.
Growing incidence of hard and heal wounds, augmenting the geriatric population, increase in the prevalence of chronic diseases, rising adoption of debridement products and techniques and growth in patients population are fuelling the market. Additionally, higher demand for improved healthcare, better reimbursement policy, high healthcare expenditure, and cost-effectiveness are the secondary factors driving the market.
On the other hand, the economic downturn is inhibiting the growth of the market.
This research report segmented and sub-segmented into the following categories:
Asia is anticipated to show a high growth rate in the market in the aforementioned forecast period owing to the rising demand for better healthcare facilities, acceptance of advanced wound debridement products, improved healthcare infrastructure and growing patient population in the region.
The Top companies leading in the APAC Wound Debridement Products Market profiled in the report are Coloplast A/S, ArthroCare Corporation, Advanced Medical Solutions Group plc, and Misonix, Inc. Other players in the market include MediWound Ltd, Derma Sciences, Inc., PuriCore plc and Smith & Nephew Plc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Method of debridement
5.1.1 Introduction
5.1.2 Selective methods
5.1.2.1 Larvae debridement therapy or bio-surgical debridement
5.1.2.2 Enzymatic or chemical debridement
5.1.2.3 Autolytic debridement
5.1.3 Non-selective methods
5.1.3.1 Mechanical debridement
5.1.3.2 Ultrasound
5.1.3.3 Sharp and surgical debridement
5.1.4 Y-o-Y Growth Analysis, By Method of debridement
5.1.5 Market Attractiveness Analysis, By Method of debridement
5.1.6 Market Share Analysis, By Method of debridement
5.2 Type of wound
5.2.1 Introduction
5.2.2 Acute wounds
5.2.2.1 Surgical wounds
5.2.2.2 Traumatic wounds
5.2.2.3 Abrasions
5.2.2.4 Necrotizing fasciitis
5.2.2.5 Lacerations
5.2.2.6 Contusions
5.2.2.7 Toxic epidermal necrolysis
5.2.3 Burn wounds
5.2.3.1 Chemical burns
5.2.3.2 Electrical burns
5.2.3.3 Flash burns
5.2.3.4 Radiation burns
5.2.3.5 Thermal burns
5.2.4 Chronic wounds
5.2.4.1 Diabetic ulcers
5.2.4.2 Venous ulcers
5.2.4.3 Pressure ulcers
5.2.5 Y-o-Y Growth Analysis, By Type of wound
5.2.6 Market Attractiveness Analysis, By Type of wound
5.2.7 Market Share Analysis, By Type of wound
5.3 Product
5.3.1 Hydrosurgical Debridement Devices
5.3.2 Low Frequency Ultrasound Devices
5.3.3 Surgical Wound Debridement Devices
5.3.4 Mechanical Debridement Pads
5.3.5 Traditional Wound Debridement Devices
5.3.6 Larval Therapy
5.3.7 Y-o-Y Growth Analysis, By Product
5.3.8 Market Attractiveness Analysis, By Product
5.3.9 Market Share Analysis, By Product
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Method of debridement
6.1.3.3 By Type of wound
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Method of debridement
6.1.4.3 By Type of wound
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Method of debridement
6.1.5.3 By Type of wound
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Advanced Medical Solutions Group plc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Coloplast A/S
8.3 ArthroCare Corporation
8.4 Misonix, Inc.
8.5 Derma Sciences, Inc.
8.6 MediWound Ltd
8.7 PuriCore plc
8.8 Smith & Nephew Plc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
